Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Cathepsins L and B are lysosomal cysteine proteinases whose activities and cellular location are altered in many types of cancers and cancer cell lines. Cathepsins L and B play an unspecified role in cancer invasion and metastasis. The purpose of our study was to determine whether cathepsins L and B are important for the ability of two prostate cancer cell lines, PC3 and DU 145, to invade the basement membrane-like preparation, Matrigel. Exposure of PC3 and DU145 to the irreversible cysteine proteinase inhibitor, E64, decreases the invasive ability of DU145, but not PC3. PC3 and DU145 were treated with the phorbol ester analogue, phorbol 12-myristate 13-acetate (PMA), a known tumor promoter that activates protein kinase C and contributes to the metastatic phenotype. PMA increased secreted cathepsin L+B activity and the invasive ability of PC3 and DU145; co-exposure to E64 and PMA decreased both cathepsin L+B activity and invasion. We conclude that DU145 requires cathepsin L+B activity more than PC3 for the invasion of the Matrigel. When the amount of secreted cathepsin L+B activity is increased by PMA treatment, however, PC3 becomes dependent on cathepsin L+B for invasion. Our study demonstrates that modulation of the amount of secreted cathepsin L+B activity influences the invasive phenotype of PC3 and DU145.
Colella
R
R
Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA. r0cole01@gwise.louisville.edu
Jackson
T
T
Goodwyn
E
E
D002401:Cathepsin B / Q000187:drug effects / Q000378:metabolism*; D056668:Cathepsin L; D002403:Cathepsins / Q000187:drug effects / Q000378:metabolism*; D002452:Cell Count / Q000379:methods; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D003094:Collagen; D003546:Cysteine Endopeptidases / Q000187:drug effects / Q000378:metabolism*; D004338:Drug Combinations; D006801:Humans; D007797:Laminin; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology* / Q000503:physiopathology*; D009367:Neoplasm Staging / Q000379:methods; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology*; D011509:Proteoglycans; D013755:Tetradecanoylphorbol Acetate
D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D003094:Collagen; D002403:Cathepsins; D003546:Cysteine Endopeptidases; D002401:Cathepsin B; C534281:CTSL protein, human; D056668:Cathepsin L; D013755:Tetradecanoylphorbol Acetate